Results from genetic association studies have begun to shed light on the genetic risk conferred by an IRF5 risk haplotype; however, to date, these studies have only been associative/correlative with other clinical manifestations of SLE, e.g. serum IFNα activity, autoantibody production and gene expression [18], [35]. The gene discussed is IRF5; the disease is systemic lupus erythematosus.